Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

The term macrophage activation syndrome (MAS) refers to a potentially lifethreatening
complication of rheumatic disorders that is seen most commonly in systemic juvenile …

… Angelo Ravelli,1 Francesca Minoia,2 Sergio Dav`ı,2 AnnaCarin Horne,3 Francesca Bovis,2 …
Strippoli R, Caiello I, de Benedetti F. Reaching the threshold: a multilayer pathogenesis of …

Macrophage activation syndrome (MAS) is increasingly recognized among febrile hospitalized
patients. Clinically, MAS resembles multiorgan dysfunction and shock. Laboratory …

Objective To describe the clinical, laboratory, and histopathologic features, current treatment,
and outcome of patients with macrophage activation syndrome (MAS) complicating …

Background Immunomodulants have been proposed to mitigate severe acute respiratory
syndrome coronavirus 2–induced cytokine storm, which drives acute respiratory distress …

… Notably, the characteristics of patients with MAS enrolled by rheumatologists and those
enrolled by hemato-oncologists were comparable (Minoia F et al: unpublished observations). In …

Objective To assess performance of the 2016 macrophage activation syndrome ( MAS )
classification criteria for patients with systemic juvenile idiopathic arthritis ( JIA ) who develop …

Objective To develop and validate a diagnostic score that aids in identifying macrophage
activation syndrome (MAS) in patients with systemic juvenile idiopathic arthritis (sJIA). Methods …

Coronavirus disease 19 is a global healthcare emergency with a high lethality rate. Relevant
inflammatory cytokine storm is associated with severity of disease, and IL1 inhibition is a …